RE:RE:Does anyone seen the Advertisement Would BTD help speed up the enrollment? If it were me I would first consider the superior results, the ridiculous low number of treatments compared to the competition and of course the safety profile but for those that need more validation an approval from the FDA wouldn't hurt.
As you say they don't really need 100 patients to be considered for BTD and AA but it would complete Phase II and remove just one more reason to sow doubt for those pathetic enough to still be playing that game.
DJDawg wrote:
Nope. 63 treated. Goal is 100 as that is the most typical goal. They are laying this out in the most conservative fashion possible as RDW was burned in the past for seeming to promise things or build up expectations ahead of time (about a physiotherapy laser).
The real hope is that even before the enrollment is 100 that the numbers are good enough to warrant BTD, and even AA. It's about stats. If you have 100 patient the margin of error is around 10%. So you need a good enough sample size AND a good enough CR% that the stats still look good.
The other hope is that the stats look good enough to get the momentum going on JV and other things so that the timeline is not as critical to getting the share price above the current lows.